Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Genitourinary 1

Conditions

Smoldering Multiple Myeloma 1Prostatic Neoplasms 1Multiple Myeloma 1Monoclonal Gammopathy of Undetermined Significance 1

Interventions

Darbepoetin alfa 2piperine 1fludarabine phosphate 1ferrous sulfate 1ferric gluconate 1Whole-Body Irradiation 1Urination 1Therapeutics 1Sucrose 1Rituximab 1Phenytoin 1Peripheral Blood Stem Cell Transplantation 1Oxycodone 1Mycophenolic Acid 1Morphine 1Methotrexate 1Methadone 1Metformin 1KW-2478 1Hsp90 inhibitor KU757 1Granulocyte Colony-Stimulating Factor 1Gene Expression Profiling 1Fentanyl 1Fatty Acids, Omega-3 1Epoetin Alfa 1Early Intervention, Educational 1Cyclosporine 1Curcumin 1Celecoxib 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Monoclonal Gammopathy of Undetermined Significance × piperine × Clear all
NCT04731844 2026-05-12

Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer

University of Rochester

Phase 2 Completed
30 enrolled 13 charts
GenitourinaryPlasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡